+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of drug resistance in clinical isolates of tuberculosis from GCC: a literature review from January 2002 to March 2013



Prevalence of drug resistance in clinical isolates of tuberculosis from GCC: a literature review from January 2002 to March 2013



Journal of Infection in Developing Countries 8(9): 1137-1147



The prevalence of drug resistance in clinical isolates of Mycobacterium tuberculosis from the Gulf Cooperation Council (GCC; Saudi Arabia, Qatar, Bahrain, Kuwait, Oman, United Arab Emirates [UAE]) countries was appraised using reports published between January 2002 and March 2013. A total of 11,393 tuberculosis (TB) isolates from the GCC were studied through published literature and were analyzed statistically. Most of the isolates were resistant to isoniazid, followed by streptomycin, rifampin, ethambutol, and pyrazinamide. The highest prevalence rate of multidrug-resistant-TB (MDR-TB) was found in UAE (9.2%), followed by Kuwait (5.9%) and Saudi Arabia (4.3%). The overall MDR-TB prevalence rate was recorded as 4.0% in the entire GCC region. Automated linear modeling revealed that isoniazid resistance had a strong relationship with the prevalence of MDR-TB in all the GCC countries and was found to be the strongest predictor for MDR-TB. Interestingly, rifampicin resistance was significantly associated with the prevalence of MDR-TB in Oman, Kuwait, and Saudi Arabia, while isoniazid was identified for UAE. On the basis of a number of reports and isolates, the principal component analysis showed that, among all GCC member countries, the highest burden of TB was in Saudi Arabia and Kuwait, and maximum drug resistance was present in UAE. The study demonstrates that the prevalence of MDR-TB in GCC countries is almost equal to other developing and developed countries, and requires immediate attention for surveillance and control.

(PDF emailed within 1 workday: $29.90)

Accession: 055157346

Download citation: RISBibTeXText

PMID: 25212078


Related references

Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review. Journal of Infection 75(5): 433-440, 2017

Correlations between drug resistance of Beijing/W lineage clinical isolates of Mycobacterium tuberculosis and sublineages: a 2009-2013 prospective study in Xinjiang province, China. Medical Science Monitor 21(): 1313-1318, 2015

Clinical significance of the drug resistance of mycobacterium tuberculosis in tuberculosis control review of information from the world health organization and foreign literature. Problemy Tuberkuleza: 72-78, 1968

Prevalence and clinical distribution of multidrug-resistant bacteria (3537 isolates) in a tertiary Chinese hospital (January 2012-December 2013). Pathologie-Biologie 63(1): 21-23, 2016

Prevalence of drug resistance among M. tuberculosis isolates in Indore (M.P.). Indian Journal of Medical Microbiology 20(4): 228; Author Reply 228-228; Author Reply 228, 2007

Antimicrobial susceptibility patterns of clinical Escherichia coli isolates from dogs and cats in the United States: January 2008 through January 2013. Veterinary Microbiology 179(3-4): 287-295, 2016

The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates. Zhonghua Jie He He Hu Xi Za Zhi 33(7): 505-509, 2011

Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates. Journal of Microbiology, Immunology, and Infection 49(3): 439-444, 2015

Quarterly Communicable Disease Review: January to March 2002. Journal of Public Health Medicine 24(3): 232-238, 2003

Study of drug resistance and molecular typing of 59 cholerae01 clinical isolates from 1984 to 2002 in Chongqing, China. International Journal of Clinical and Experimental Medicine 6(10): 930-936, 2013

Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates. Bmc Infectious Diseases 15(): 153-153, 2015

Trends in older adult nonmedical prescription drug use prevalence: Results from the 2002-2003 and 2012-2013 National Survey on Drug Use and Health. Addictive Behaviors 60(): 219-222, 2016

Prevalence and correlates of depression among Australian women: a systematic literature review, January 1999- January 2010. Bmc Research Notes 6(): 424-424, 2014

Mycobacterial Prevalence and Antibiotic Resistance Frequency Trends in Taiwan of Mycobacterial Clinical Isolates From 2002 to 2014. Medicine 95(12): E2942-E2942, 2016

Assess drug resistance pattern and genetic profile of Mycobacterium tuberculosis clinical isolates by molecular typing methods using direct repeats and iIS6110 in pulmonary tuberculosis cases. Lung India 34(2): 155-159, 2017